Pre-treatment levels of circulating free IGF-1 identify NSCLC patients who derive clinical benefit from figitumumab
- Gualberto, A.
- Hixon, M.L.
- Karp, D.D.
- Li, D.
- Green, S.
- Dolled-Filhart, M.
- Paz-Ares, L.G.
- Novello, S.
- Blakely, J.
- Langer, C.J.
- Pollak, M.N.
ISSN: 1532-1827, 0007-0920
Année de publication: 2011
Volumen: 104
Número: 1
Pages: 68-74
Type: Article